Growth hormone attenuation of epidermal growth factor-induced mitogenesis

Journal of Cellular Physiology

Volumn 173, Issue 1, 1997, Pages 44-53

  Wiepz, Gregory J ^a,b   Houtman, Jon C D ^a,b   Cha, Donald ^a   Bertics, Paul J ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH HORMONE;

ARTICLE; CELL GROWTH; CELL TYPE; DNA SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL CYCLE; CYCLINS; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; MICE; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; S PHASE; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

MURINAE;

EID: 0030833222     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199710)173:1<44::AID-JCP6>3.0.CO;2-J     Document Type: Article

References (60)

1. Argetsinger, L.S., Campbell, G.S., Yang, X., Witthuhn, B.A., Silvennoinen, O., Ihle, J.N., and Carter-Su, C. (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell, 74:237-244.
2. Baldin, V., Lukas, J., Marcote, M.J., Pagano, M., and Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 7:812-821.
3. Beguinot, L., Hanover, J.A., Ito, S., Richert, N.D., Willingham, M.C., and Pastan, I. (1985) Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors. Proc. Natl. Acad. Sci. U.S.A., 82:2774-2778.
4. Bertics, P.J., Weber, W., Cochet, C., and Gill, G.N. (1985) Regulation of the epidermal growth factor receptor by phosphorylation. J. Cell Biochem., 29:195-208.
5. Billestrup, N., and Nielson, J.H. (1991) The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor I. Endocrinology, 129:883-888.
6. Campbell, G.S., Pang, L., Miyasaka, T., Saltiel, A.R., and Carter-Su, C (1992) Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J. Biol. Chem., 267:6074-6080.
7. Campbell, G.S., Meyer, D.J., Raz, R., Levy, D.E., Schwartz, J., and Carter-Su, C. (1995) Activation of acute phase response factor (APRF)/STAT3 transcription factor by growth hormone. J. Biol. Chem., 270:3974-3979.
8. Camplejohn, R.S. (1994) The measurement of DNA content alone or combined with other markers. In: Flow Cytometry (Clinical Applications). M.G. Masey, ed. Blackwell Scientific, Oxford, pp. 223-224.
9. Carpenter, G., and Cohen, S. (1990) Epidermal growth factor. J. Biol. Chem., 265:7709-7712.
10. Clark, A.J., Ishii, S., Richert, N., Merlino, G.T., and Pastan, I. (1985) Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. U.S.A., 82:8374-8378.
11. Coats, S., Flanagan, W.M., Nourse, J., and Roberts, J.M. (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272:877-880.
12. Cochet, C., Gill, G.N., Meisenhelder, J., Cooper, J.A., and Hunter, T. (1984) C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine kinase activity. J. Biol. Chem., 259:2553-2558.
13. Coker, K.J., Staros, J.V., and Guyer, C.A. (1994) A kinase-negative epidermal growth factor that retains the capacity to stimulate DNA synthesis. Proc. Natl. Acad. Sci. U.S.A., 91:6967-6971.
14. Corin, R.E., Guller, S., Wu, K.-Y., and Sonenburg, M. (1990) Growth hormone and the adipose differentiation: Growth hormone-induced antimitogenic state in 3T3-F442A preadipose cells. Proc. Natl. Acad. Sci. U.S.A., 87:7507-7511.
15. Cunningham, B.C., Ultsch, M., De Vos, A.M., Mulkerrin, M.G., Clauser, K.R., and Wells, J.A. (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hor-mone molecule. Science, 254:821-825.
16. Doglio, A., Dani, C., Grimaldi, P., and Ailhaud, G. (1989) Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc. Natl. Acad. Sci. U.S.A., 86:1148-1152.
17. Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M. (1993) TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74:1009-1020.
18. Foster, C.M., Shafer, J.A., Wang, X., Lewis, S.D., Renken, D.A., Natale, J.E., Schwartz, J., and Carter-Su, C. (1988) Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes. Biochemistry, 27:326-334.
19. Fuh, G., Cunningham, B.C., Fukunaga, R., Nagata, S., Goeddel, D.V., and Wells, J.A. (1992) Rational design of potent antagonists to the human growth hormone receptor. Science, 256:1677-1680.
20. Gala, R.R. (1991) Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med., 198:513-527.
21. Gronowski, A.M., and Bertics, P.J. (1995) Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity. Endocrinology, 136:2198-2205.
22. Gronowski, A.M., and Rotwein, P. (1994) Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. J. Biol. Chem., 269:7874-7878.
23. Gronowski, A.M., Zhong, Z., Wen, Z., Thomas, M.J., Darnell, J.E.J., and Rotwein, P. (1995) In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of STAT3. Mol. Endocrinol., 9:171-177.
24. Halevy, O., Novitch, B.G.S., Picer, D.B., Skapek, S.X., Rhee, J., Beach, D., and Lasser, A.B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267:1018-1021.
25. Handler, J.A., Danilowicz, R.M., and Eling, T.E. (1990) Mitogenic signalling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/ c 3T3 cells. J. Biol. Chem., 265:3669-3673.
26. Heisermann, G.J., Wiley, H.S., Walsh, B.J., Ingrahm, H.A., Fiol, C.J., and Gill, G.N. (1990) Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the EGF receptor. J. Biol. Chem., 265:12820-12827.
27. Jeoung, D.I., Tang, B., and Sonenberg, M. (1995) Mitogenic response to TGF-beta in 3T3-F442A cells. Biochem. Biophys. Res. Commun., 216:964-969.
28. Kelly, P.A., Djiane, J., Postel-Vinay, M.C., and Edery, M. (1991) The prolactin/growth hormone receptor family. Endocrine Rev., 12:235-251.
29. Kleinberg, D.L., Ruan, W., Catanese, V., Newman, C.B., and Feldman, M. (1990) Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-1 mRNA of rat mammary gland. Endocrinology, 129:883-888.
30. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J.M., and Massague, J. (1993) Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β. Science, 260:536-539.
31. Kraus, M.H., Popescu, N.U., Amsbaugh, S.C., and King, C.R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6:605-610.
32. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., and Aaronson, S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBB3/epidermal growth factor receptor family: Evidence for Overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. U.S.A., 86:9193-9197.
33. Laiho, M., DeCaprio, J.A., Ludlow, J.W., Livingston, D.M., and Massague, J. (1990) Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62:175-185.
34. Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature, 313:144-147.
35. Magun, B.E., Martrisian, L.M., and Bowden, G.T. (1980) Epidermal growth factor. J. Biol. Sci., 255:6373-6381.
36. Merimee, T.J. (1979) Growth hormone: Secretion and action. In Endocrinology. Edited by DeGroot, L.J., Grune & Stratton, New York, pp. 123-132.
37. Meyerson, M., Enders, G., Wu, C.L., Su, L.K., Nelson, C., Harlow, E., and Tsai, L.H. (1992) A family of human cdc2-related protein kinases. EMBO J., 11:2909-2917.
38. Moller, C., Hansson, A., Enberg, B., Lobie, P.E., and Norstedt, G. (1992) Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J. Biol. Chem., 267:23403-23408.
39. Morikawa, M., Nixon, T., and Green, H. (1982) Growth hormone and the adipose conversion of 3T3 cells. Cell, 29:783-789.
40. Norbury, C., and Nurse, P. (1992) Animal cell cycles and their control. Annu. Rev. Biochem., 61:441-470.
41. Northwood, I.C., Gonzalez, F.A., Wartmann, M., Raden, D.L., and Davis, R.J. (1991) Isolation and characterization of two growth-factor stimulated protein kinases that phosphorylate the EGF receptor. J. Biol. Chem., 266:15266-15276.
42. Parker, S.B., Eichele, G., Zhang, P., Rawls, A., Sands, A.T., Bradley, A., Olson, E.N., Harper, J.W., and Elledge, S.J. (1995) p53-independent expression of p21cip1 in muscle and other terminally differentiating cells. Science, 267:1024-1027.
43. Peters, G. (1994) Stifled by inhibitions. Nature, 371:204-205.
44. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78:59-66.
45. Quelle, D.E., Ashmun, R.A., Shurtleff, S.A., Kato, J.Y., Bar-Sagi, D., Roussel, M.F., and Sherr, C.J. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7:1559-1571.
46. Ridderstråle, M., Degerman, E., and Tornqvist, H. (1995) Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem., 270:3471-3474.
47. Serano G (1987) EGF inhibits the differentiation of adipocyte precursors in primary cell cultures. Biochem. Biophys. Res. Commun., 146:194-202.
48. Shechter, Y., Hernaez, L., and Cuatrecasas, P. (1978) Epidermal growth factor: Biological activity requires persistent occupation of high-affinity cell surface receptors. Proc. Natl. Acad. Sci. U.S.A., 75:5788-5791.
49. Sherr, C. (1993) Mammalian G1 cyclins. Cell, 73:1059-1065.
50. Sherr, C.J. (1995) D-type cyclins. Trends Biochem. Sci., 20:187-190.
51. Sinha, Y.N. (1980) Molecular size variants of prolactin and growth hormone in mouse serum: Strain differences and alterations of concentrations by physiological and pharmacological stimuli. Endocrinology, 107:1959-1969.
52. 3H]thymidine incorporation, cell cycle progression, and cyclin D expression in 3T3-F442A preadipose cells. Endocrinology, 136:3062-3069.
53. Toyoshima, H., and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78:67-74.
54. VanderKuur, J., Allevato, G., Billestrup, N., Norstedt, G., and CarterSu, C. (1995) Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem., 270:7587-7593.
55. Weigent, D.A., Blalock, J.E., and LeBoeuf, R.D. (1991) An antisense oligodeoxynucleotide to growth hormone mRNA inhibits lymphocyte proliferation. Endocrinology, 128:2053-2057.
56. Winston, L.A., and Bertics, P.J. (1992) Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J. Biol. Chem., 267:4747-4751.
57. Winston, L.A., and Hunter, T. (1995) JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem., 270:30837-30840.
58. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., Pastan, I., Gamou, S., and Shimizu, N. (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46:414-416.
59. Yokota, J., Yamamoto, T., Toyoshima, K., Terada, M., Sugimura, T., Battifora, H., and Cline, M. (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, 1:765-767.
60. Zandik, Z., Chalew, S.A., McCarter, R.J., Meistas, M., and Kowarski, A.A. (1985) The influence on age on the 24-hour intergrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab., 60:513-516.